Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
PERPHENAZINE
Mercury Pharmaceuticals Ltd
4 Milligram
Coated Tablets
2005-08-26
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0899/029/002 Case No: 2043122 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to GOLDSHIELD PHARMACEUTICALS LTD NLA TOWER, 12-16 ADDISCOMBE ROAD,CROYDON, CROYDON, SURREY CRO 0XT, ENGLAND an authorisation, subject to the provisions of the said Regulations, in respect of the product FENTAZIN 4MG COATED TABLETS The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 27/11/2007 until 17/09/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 29/11/2007_ _CRN 2043122_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fentazin 4 mg Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 4 mg of perphenazine. Excipients: Lactose monohydrate 129.52 mg Sucrose 128.72 mg Butyl parahydroxybenzoate 6 micrograms For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablet Biconvex, white, sugar-coated tablets with the code ‘2C’ on one face. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an adjunct to the short term management of anxiety, severe psychomotor agitation, excitement, violent or dangerously impulsive behaviour, schizophrenia, treatment of sy Přečtěte si celý dokument